目錄:MedChemExpress LLC>>信號通路>> GLPG1205 | MCE
CAS | 1445847-37-9 | 純度 | 99.64% |
---|---|---|---|
分子量 | 378.42 | 分子式 | C??H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-135303 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
產(chǎn)品活性:GLPG1205 是有效的選擇性,具有口服活性的 GPR84 (G 蛋白偶聯(lián)受體)拮抗劑,表現(xiàn)出良好的 PK/PD 特征。GLPG1205 具有抗炎活性,可用于肺纖維化的相關(guān)研究。
研究領(lǐng)域:GPCR/G Protein
作用靶點:GPR84
In Vitro: GLPG1205 (0.5?μM) completely inhibits the ZQ16-induced [Ca2+]i response in neutrophils.
GLPG1205 (1?μM; for 5?min) completely blocks the ROS-response induced by the GPR84-agonist.
GLPG1205 can potently antagonizes ZQ16-induced ROS with an IC50 value of 15?nM in TNF-α primed neutrophils.
In Vivo: GLPG1250 (orally adminstation; 30mg/kg; twice daily) for 2 weeks, starts from 7 days post-challenge,greatly reduces the Ashcroft score, in idiopathic pulmonary fibrosis model.GLPG1250 (orally adminstation; 30mg/kg; once daily) starts from 18 weeks post irradition, significantly reduces college deposition in the mouse lung. Additionlly, GLPG1250 inhibits the increase in MnSOD in lung bronchial epithelial cells and parenchymal macrophages, in the irradiation model.GLPG1205 dose dependently decreases disease activity, histological activity, neutrophil influx and colonic MPO content,in a mouse IBD model.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Orally Active Compound Library | Targeted Diversity Library | Anti-Pulmonary Fibrosis Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | 6-OAU | Fezagepras | GPR84 antagonist 8 | ZQ-16 | GPR84 antagonist 1 | GPR84 antagonist 2 | GPR84 antagonist 3
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)